Inogen (INGN) Assets (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.25% |
| Dec 31, 2025 | -2.73% |
| Sep 30, 2025 | -1.61% |
| Jun 30, 2025 | 1.18% |
| Mar 31, 2025 | 4.13% |
| Dec 31, 2024 | -3.26% |
| Sep 30, 2024 | -0.89% |
| Jun 30, 2024 | -2.12% |
| Mar 31, 2024 | -3.25% |
| Dec 31, 2023 | -5.09% |
| Sep 30, 2023 | -8.19% |
| Jun 30, 2023 | -2.94% |
| Mar 31, 2023 | -4.78% |
| Dec 31, 2022 | -13.74% |
| Sep 30, 2022 | -0.10% |
| Jun 30, 2022 | -0.96% |
| Mar 31, 2022 | -3.04% |
| Dec 31, 2021 | -4.55% |
| Sep 30, 2021 | 2.95% |
| Jun 30, 2021 | 4.55% |
| Mar 31, 2021 | 3.17% |
| Dec 31, 2020 | 0.33% |
| Mar 31, 2020 | 2.63% |
| Dec 31, 2019 | 0.59% |
| Sep 30, 2019 | 10.14% |
| Jun 30, 2019 | 4.01% |
| Mar 31, 2019 | 3.27% |
| Dec 31, 2018 | 5.26% |
| Sep 30, 2018 | 7.36% |
| Jun 30, 2018 | 10.92% |
| Mar 31, 2018 | 9.02% |
| Dec 31, 2017 | 1.94% |
| Sep 30, 2017 | 7.41% |
| Jun 30, 2017 | 10.37% |
| Mar 31, 2017 | 6.34% |
| Dec 31, 2016 | 1.29% |
| Sep 30, 2016 | 6.98% |
| Jun 30, 2016 | 9.26% |
| Mar 31, 2016 | 12.07% |
| Dec 31, 2015 | 2.44% |
| Sep 30, 2015 | 0.17% |
| Jun 30, 2015 | 5.89% |
| Mar 31, 2015 | 5.98% |
| Dec 31, 2014 | 2.14% |
| Sep 30, 2014 | -5.71% |
| Jun 30, 2014 | 7.35% |
| Mar 31, 2014 | 64.46% |